CBER Publishes 2017 Guidance Agenda

Drug Industry Daily
A A
CBER released a set of guidance topics that the center is considering for development this year, covering blood and blood components, tissues and advanced therapies, and chemistry, manufacturing and controls changes.

To View This Article:

Login

Subscribe To Drug Industry Daily